Soleus Capital Management’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-261,147
Closed -$2.91M 102
2025
Q2
$2.91M Sell
261,147
-340,778
-57% -$4.22M 0.19% 70
2025
Q1
$9.82M Sell
601,925
-84,449
-12% -$1.48M 0.71% 38
2024
Q4
$12M Buy
686,374
+79,441
+13% +$1.38M 0.75% 35
2024
Q3
$9.48M Buy
606,933
+555,933
+1,090% +$8.91M 0.73% 40
2024
Q2
$676K Buy
+51,000
New +$699K 0.06% 86
2023
Q1
Sell
-295,300
Closed -$6.06M 91
2022
Q4
$6.06M Buy
+295,300
New +$5.21M 0.87% 34

Other funds holding OFIX

Soleus Capital Management's OFIX Position: Q3 2025 in Review

Soleus Capital Management sold out of Orthofix Medical (OFIX) in Q3 2025, closing a stake of 261,147 shares — an estimated $2.91M sold.

Soleus Capital Management first reported a position in OFIX in Q4 2022 and held it in 6 quarters. The position peaked at $12M in Q4 2024. 144 funds tracked by Wall St. Rank hold OFIX as of Q3 2025.

  • Soleus Capital Management reported no remaining Orthofix Medical position as of Q3 2025 after selling out during the quarter.
  • Soleus Capital Management sold 261,147 Orthofix Medical shares in Q3 2025, an estimated $2.91M.
  • Soleus Capital Management first reported a position in Orthofix Medical in Q4 2022 and held it in 6 quarters.
  • Soleus Capital Management's Orthofix Medical position peaked at $12M in Q4 2024.
  • 144 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2025.

Based on Soleus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.